Application 017588

Type
NDA
Sponsor
CORDEN PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GLEOSTINELOMUSTINECAPSULE;ORAL10MGYesNo
002GLEOSTINELOMUSTINECAPSULE;ORAL40MGYesNo
003GLEOSTINELOMUSTINECAPSULE;ORAL100MGYesYes
004GLEOSTINELOMUSTINECAPSULE;ORAL5MGYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N017588-001GLEOSTINELOMUSTINE10MGCAPSULE / ORALABRLD, Approved before 1982
N017588-002GLEOSTINELOMUSTINE40MGCAPSULE / ORALABRLD, RS, Approved before 1982
N017588-003GLEOSTINELOMUSTINE100MGCAPSULE / ORALABRLD, Approved before 1982
N017588-004GLEOSTINELOMUSTINE5MGCAPSULE / ORALRLD2014-12-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
N017588-001AB
N017588-002AB
N017588-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N017588-001GLEOSTINE10MGCAPSULE / ORALABRLD, Approved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N017588-002GLEOSTINE40MGCAPSULE / ORALABRLD, RS, Approved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N017588-003GLEOSTINE100MGCAPSULE / ORALABRLD, Approved before 1982caaa826d4ba7…
2026-08-18 06:07:402026-07N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N017588-001GLEOSTINE10MGCAPSULE / ORALABRLD, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017588-002GLEOSTINE40MGCAPSULE / ORALABRLD, RS, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017588-003GLEOSTINE100MGCAPSULE / ORALABRLD, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017588-001GLEOSTINE10MGCAPSULE / ORALABRLD, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017588-002GLEOSTINE40MGCAPSULE / ORALABRLD, RS, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017588-003GLEOSTINE100MGCAPSULE / ORALABRLD, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, RS, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, RS, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, RS, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, RS, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, RS, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, RS, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 1982d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, RS, Approved before 1982d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, Approved before 1982d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-19d8e5a09893c0…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07N017588-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07N017588-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07N017588-003AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N017588-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017588-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017588-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017588-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017588-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017588-003AB131067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N017588-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N017588-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N017588-003AB1a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LomustineLOMUSTINEWilshire Pharmaceuticals, Inc.3c3637fc-4499-4331-a3c4-6969fc86704e2026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 017588
application number: NDA017588
GleostineLOMUSTINEAzurity Pharmaceuticals, Inc.3529fe2f-3c23-4862-bb20-b480269570822025-09-25Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 017588
application number: NDA017588
GleostineLOMUSTINENextSource Biotechnology, LLC7f77526b-4c40-409c-82ea-d0f934d89cc22024-01-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 017588
application number: NDA017588
ndc (product): 58181-3040
ndc (product): 58181-3042
ndc (product): 58181-3041

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 9 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
58181-3040GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3040GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3040GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3041GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3041GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3041GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3042GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3042GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3042GleostinelomustineNextSource Biotechnology, LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
64854SUPPL2020-10-06
63588SUPPL2020-06-17
33317SUPPL2016-02-02
13864SUPPL2016-02-01
11042SUPPL2016-01-07
661SUPPL2016-01-07
33316SUPPL2014-05-28
660SUPPL2014-05-22
11041SUPPL2013-08-21
11040SUPPL2012-11-28
658SUPPL2012-11-23
33315SUPPL2011-05-16
659SUPPL2011-05-16
33314SUPPL2009-05-11
657SUPPL2009-05-06
656SUPPL2003-03-10
655SUPPL2002-12-20